Cisplatin-Based First-Line Therapy for Advanced Urothelial Carcinoma After Previous Perioperative Cisplatin-Based Therapy

Longer time from previous perioperative chemotherapy (TFPC) ≥ 78 weeks and Eastern Cooperative Oncology Group (ECOG) performance status (PS) = 0 were independently prognostic for better survival with cisplatin-based first-line chemotherapy for advanced urothelial carcinoma (UC) after previous periop...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Clin Genitourin Cancer
Autori principali: Necchi, Andrea, Pond, Gregory R., Giannatempo, Patrizia, Di Lorenzo, Giuseppe, Eigl, Bernhard J., Locke, Jenn, Pal, Sumanta K., Agarwal, Neeraj, Poole, Austin, Vaishampayan, Ulka N., Niegisch, Guenter, Hussain, Syed A., Singh, Parminder, Bellmunt, Joaquim, Sonpavde, Guru
Natura: Artigo
Lingua:Inglês
Pubblicazione: 2014
Soggetti:
Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC4477939/
https://ncbi.nlm.nih.gov/pubmed/25450035
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.clgc.2014.08.010
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi